H36.829
Proliferative sickle-cell retinopathy, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Proliferative sickle-cell retinopathy is a serious eye condition that affects people with sickle cell disease. It involves abnormal blood vessel growth in the retina, which can lead to vision problems or even blindness if left untreated. This condition primarily impacts the retina, the light-sensitive tissue at the back of the eye essential for good vision. Recognizing the signs and understanding the nature of this condition can help in managing and seeking appropriate care promptly.
Causes & Symptoms
Clinical Causes: Sickle cell disease: a genetic blood disorder characterized by abnormal, rigid, sickle-shaped red blood cells. Poor circulation in the tiny blood vessels of the retina, caused by sickled cells blocking or damaging these vessels. Genetic predisposition: inherited traits that influence the severity and risk of developing retinopathy. Progressive damage due to recurrent blockages and ischemia (lack of blood flow) in retinal tissues.
Key Symptoms: Gradual loss of vision or blurred vision over time. Seeing floaters or spots in the field of vision. Dark areas or field loss in the peripheral or central vision. In some cases, no noticeable symptoms until the disease advances.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of proliferative sickle-cell retinopathy involves a comprehensive eye examination by an ophthalmologist. Key diagnostic tools include: - **Fundoscopic exam:** using specialized lenses to inspect the retina for abnormal blood vessels and hemorrhages. - **Fluorescein angiography:** an imaging technique where a dye is injected to highlight blood flow in retinal vessels and detect neovascularization. - **Optical coherence tomography (OCT):** a non-invasive imaging method that provides detailed cross-sectional images of retinal tissue to identify edema or structural changes. Early detection through regular eye exams is crucial for preventing severe vision loss.
Treatment Protocols: Management of proliferative sickle-cell retinopathy aims to prevent progression and preserve vision. Treatment options include: - **Laser photocoagulation:** using laser therapy to destroy abnormal blood vessels and prevent bleeding. - **Cryotherapy:** applying extreme cold to freeze and seal faulty vessels, especially in peripheral areas. - **Vitrectomy:** a surgical procedure to remove blood, scar tissue, or membranes in the vitreous cavity when hemorrhages or detachments occur. - **Monitoring and controlling sickle cell disease:** systemic management to reduce sickling crises and vascular complications. Patients are encouraged to have regular eye check-ups and report any changes in vision promptly. Collaboration between healthcare providers, including hematologists and ophthalmologists, is essential for comprehensive care.
Clinical Advice & FAQs
Billing Guidance
Is H36.829 a billable ICD-10 code?
Yes, H36.829 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H36.829?
Clinical documentation must specify the nature of Proliferative sickle-cell retinopathy, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference